Xiaoxiang Zhou
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Galectins and Cancer Biology
- Immune cells in cancer
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- Pancreatic and Hepatic Oncology Research 2
-
- Ferroptosis and cancer prognosis 2
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Zhuoran Yao (5 shared papers)Xuan Zhang (3 shared papers)Huaxia Yang (3 shared papers)Fengchun Zhang (1 shared paper)Naixin Liang (1 shared paper)Lejia Sun (5 shared papers)Huayu Yang (4 shared papers)Yilei Mao (3 shared papers)
- Journals
- Journal of Endovascular Therapy (2 papers)Clinica Chimica Acta (2 papers)Frontiers in Oncology (2 papers)International Journal of Biological Macromolecules (1 paper)Clinical Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoxiang Zhou
20 papers receiving 904 citations
Xiaoxiang Zhou's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 484
- Immunology 179
- Hepatology 45
- Pulmonary and Respiratory Medicine 101
- Cancer Research 36
Countries citing papers authored by Xiaoxiang Zhou
This map shows the geographic impact of Xiaoxiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiang Zhou more than expected).
Fields of papers citing papers by Xiaoxiang Zhou
This network shows the impact of papers produced by Xiaoxiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiang Zhou. The network helps show where Xiaoxiang Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxiang Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 283 | |
| 2 | Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis Hit paper breakdown → | 2021 | 195 |
| 3 | 2019 | 123 | |
| 4 | 2020 | 64 | |
| 5 | 2019 | 62 | |
| 6 | 2018 | 59 | |
| 7 | 2019 | 33 | |
| 8 | 2020 | 26 | |
| 9 | 2024 | 23 | |
| 10 | 2017 | 10 | |
| 11 | 2023 | 10 | |
| 12 | 2024 | 4 | |
| 13 | 2016 | 3 | |
| 14 | 2020 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2020 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Xiaoxiang Zhou
Xiaoxiang Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Epidemiology, having authored 21 papers that have together received 908 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (2 papers), Single-cell and spatial transcriptomics (2 papers), Abdominal vascular conditions and treatments (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), RNA and protein synthesis mechanisms (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (484 citations), Immunology (179 citations), Hepatology (45 citations), Pulmonary and Respiratory Medicine (101 citations) and Cancer Research (36 citations). Xiaoxiang Zhou has collaborated with scholars based in China and United States. Frequent co-authors include Zhuoran Yao, Xuan Zhang, Huaxia Yang, Fengchun Zhang, Naixin Liang, Lejia Sun, Huayu Yang, Yilei Mao, Gang Xu and Meixi Liu. Their work appears in journals such as Journal of Endovascular Therapy, Clinica Chimica Acta, Frontiers in Oncology, International Journal of Biological Macromolecules and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.